01Jan/13

FDA clears J&J drug for tough-to-treat TB – MarketWatch


San Francisco Chronicle

FDA clears J&J drug for tough-to-treat TB
MarketWatch
Fewer than 100 Americans have MDR-TB, according to J&J, but FDA approval is likely to strengthen the chances for approval in regions where the disease is more prevalent, including India, China and Eastern Europe. However, the drug’s potential side
FDA backs the first new drug for TB in 40 yearsPress Herald

all 464 news articles »

31Dec/12

LATEST NEWS

Randy Gideon stands by his Fort Worth, Texas home, Tuesday, Dec. 18, 2012. Last year on December 26th, the prominent Fort Worth architect got a late Christmas present, a double lung transplant.

31Dec/12

J&J Tuberculosis Drug Gets Fast-Track Clearance – Wall Street Journal


ABC News

J&J Tuberculosis Drug Gets Fast-Track Clearance
Wall Street Journal
Fewer than 100 Americans have MDR-TB, according to J&J, but FDA approval is likely to strengthen the chances for approval in regions where the disease is more prevalent, including India, China and Eastern Europe. However, the drug’s potential risks
J&J Sirturo Wins FDA Approval to Treat Drug-Resistant TBBloomberg

all 348 news articles »